Early impact of the US Tdap vaccination program on pertussis trends

Archives of Pediatrics and Adolescent Medicine

Volumn 166, Issue 4, 2012, Pages 344-349

  Skoff, Tami H ^a   Cohn, Amanda C ^a   Clark, Thomas A ^a   Messonnier, Nancy E ^a   Martin, Stacey W ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXOID; PERTUSSIS VACCINE; TETANUS TOXOID;

ADOLESCENT; ADULT; ARTICLE; CHILD; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; UNITED STATES; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; UNITED STATES; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84859400879     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2011.1093     Document Type: Article

References (40)

1. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA. 2003;290(22): 2968-2975. (Pubitemid 37505529)
2. Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics. 2008; 121(3):484-492.
3. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003;22(7):628-634. (Pubitemid 36900210)
4. Centers for Disease Control and Prevention (CDC). Pertussis: United States, 2001-2003. MMWR Morb Mortal Wkly Rep. 2005;54(50):1283-1286.
5. Hewlett EL, Edwards KM. Clinical practice: pertussis: not just for kids. N Engl J Med. 2005;352(12):1215-1222.
6. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23(11):985-989. (Pubitemid 40824285)
7. Wendelboe AM, Njamkepo E, Bourillon A, et al Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007; 26(4):293-299. (Pubitemid 46596651)
8. Nelson JD. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am J Dis Child. 1978;132(4):371-373. (Pubitemid 9129606)
9. Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis. 1995;21(5):1211-1219.
10. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among children aged 19-35 months: United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(36):1171-1177.
11. Broder KR, Cortese MM, Iskander JK, et al Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-3):1-34.
12. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005; 24(6)(suppl):S104-S108. (Pubitemid 40840106)
13. Kretsinger K, Broder KR, Cortese MM, et al Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55(RR-17):1-37.
14. Centers for Disease Control and Prevention (CDC). National vaccination coverage among adolescents aged 13-17 years: United States, 2006. MMWR Morb Mortal Wkly Rep. 2007;56(34):885-888.
15. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years: United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(32):1018-1023.
16. Centers for Disease Control and Prevention. National Health Interview Survey, 2008-2009: self-reported tetanus, diphtheria, and acellular pertussis (Tdap) vaccination coverage among adults 19-64 years in the United States (Table 2). http://www.cdc.gov/vaccines/stats-surv/nhis/2009-nhis.htm#08. Accessed August 25, 2011.
17. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155-2163. (Pubitemid 350106654)
18. Güriş D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28(6):1230-1237. (Pubitemid 29272795)
19. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance.MMWRRecomm Rep. 1997;46(RR-10): 1-55.
20. Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in Massachusetts, 1981- 1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis. 1994; 169(6):1297-1305. (Pubitemid 24164594)
21. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309. (Pubitemid 34989269)
22. Rank C, Quinn HE, McIntyre PB. Pertussis vaccine effectiveness after mass immunization of high school students in Australia. Pediatr Infect Dis J. 2009; 28(2):152-153.
23. Wei SC, Tatti K, Cushing K, et al. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis. Clin Infect Dis. 2010;51(3):315-321.
24. Isaacman DJ, Fletcher MA, Fritzell B, Ciuryla V, Schranz J. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar). Vaccine. 2007;25(13):2420-2427. (Pubitemid 46366122)
25. Haber M, Barskey A, Baughman W, et al. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine. 2007;25(29):5390-5398. (Pubitemid 46977530)
26. Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics. 2007;119(1):e22-e29. (Pubitemid 46397801)
27. Coudeville L, Van Rie A, Getsios D, Caro JJ, Crépey P, Nguyen VH. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS One. 2009;4(7): e6284.
28. Kinlin LM, Jamieson F, Brown EM, et al. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. Vaccine. 2009;27(11):1735-1740.
29. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease: United States, 1998-2003.MMWR Morb Mortal Wkly Rep. 2005;54(36):893-897.
30. Trotter CL, Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines. 2009; 8(7):851-861.
31. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74.
32. Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science. 2010;330(6006):982-985.
33. Coudeville L, van Rie A, Andre P. Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies. Epidemiol Infect. 2008;136(5):604-620. (Pubitemid 351472170)
34. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine. 2008;26(14):1786-1793.
35. Rehm SJ, Farley MM, File TMJ Jr, et al. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med. 2009;121 (6):101-105.
36. Poland GA, Shefer AM, McCauley M, Webster PS, Whitley-Williams PN, Peter G; National Vaccine Advisory Committee, Ad Hoc Working Group for the Development of Standards for Adult Immunization Practices. Standards for adult immunization practices. Am J Prev Med. 2003;25(2):144-150. (Pubitemid 36918354)
37. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52(2):157-162.
38. Westra TA, de Vries R, Tamminga JJ, Sauboin CJ, Postma MJ. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther. 2010;32(8):1479-1495.
39. McIntyre P, Wood N. Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis. 2009;22(3):215-223.
40. Centers for Disease Control and Prevention. ACIP Provisional recommendations for pregnant women on use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap). http://www.cdc.gov/vaccines/recs/ provisional/downloads/pregnant-Tdap-use.pdf. Accessed August 25, 2011.